NCT01941160已完成1 期
A Randomized, Placebo Controlled, Parallel Group Study to Evaluate the Effect of a Probiotic Product, Lacidofil® STRONG, in Healthy Adults Taking Antibiotic Treatment
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 入组人数
- 160
- 试验地点
- 2
- 主要终点
- The primary outcomes are the between group difference in mean Bristol Stool Scores (consistency) and the between group difference in the mean number of bowel movements (frequency).
研究概览
简要总结
The objectives of this study are to evaluate stool consistency and stool frequency during and up to 8 weeks following a 7 day antibiotic treatment with Amoxicillin/Clavulanic Acid 875mg BID.
详细描述
It is hypothesized that the proportion of subjects having a diarrhea-like defecation, defined as a stool frequency ≥ 3 per day and/or stool consistency ≥ 5 (Bristol Stool Score) for at least 2 days will be lower in the group receiving Lacidofil® STRONG compared to the group receiving placebo and therefore mean Bristol Stool Scores will be lower in subjects receiving Lacidofil® STRONG compared to those receiving placebo.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Prevention
- 盲法
- Triple (Participant, Investigator, Outcomes Assessor)
入排标准
- 年龄范围
- 18 Years 至 50 Years（Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Male or female aged 18 to 50 years inclusive
- •Body mass index 18.0 - 29.9 kg/m2
- •Healthy as determined by laboratory results, medical history and physical exam
- •Agrees to comply with study procedures
- •Agrees not to change current dietary habits (with the exception of avoiding pro- and prebiotics) and activity/training levels during the course of the study
- •Has given voluntary, written, informed consent to participate in the study
排除标准
- •Women who are pregnant, breastfeeding, or planning to become pregnant during the course of the trial
- •Body mass index ≥ 30 kg/m2
- •Average number of formed bowel movements > 3 per day or < 3 per week
- •Participation in a clinical research trial within 30 days prior to randomization
- •Use of antibiotics within 60 days prior to randomization.
- •Habitual use of pro- and/or prebiotic products. Subjects must not consume foods or supplements containing added pro- and/or prebiotics within 3 weeks prior to randomization and during the course of the study
- •Use of laxatives, enemas or suppositories 1 week prior to randomization and for the duration of the study
- •Follows a vegetarian or vegan diet
- •Unstable medical conditions, as determined by the Qualified Investigator
- •History of chronic gastrointestinal disorders including irritable bowel syndrome; chronic constipation; chronic diarrhea; dyspepsia; gastroesophageal reflux disease; diverticulitis; colitis; Crohn's disease; or any other malabsorption or gastrointestinal disorder
- •Subjects with an immuno-compromised condition (e.g. AIDS, lymphoma, patients undergoing long-term corticosteroid treatment)
- •Alcohol use > 2 standard alcoholic drinks per day and/or alcohol or drug abuse within past year
- •Allergy or sensitivity to test product ingredients or Amoxicillin/Clavulanic Acid
- •Individuals who are cognitively impaired and/or who are unable to give informed consent
- •Any other condition which in the Investigator's opinion may adversely affect the subject's ability to complete the study or its measures or which may pose significant risk to the subject
结局指标
主要结局
The primary outcomes are the between group difference in mean Bristol Stool Scores (consistency) and the between group difference in the mean number of bowel movements (frequency).
时间窗: Up to 63 days
次要结局
- Incidence of AAD(Up to 63 days)
- Influence of Lacidofil® STRONG on side effects associated with antibiotic use(Up to 63 days)
研究者
Dale Wilson, MD
Medical Director
KGK Science Inc.
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Effect of Lactobacillus Gasseri DSM 27123 on Functional Constipation in Healthy WomenFunctional ConstipationNCT02592200BioGaia AB40
已完成
不适用
Gastrointestinal Tolerance And General Health Status Of Healthy Term Infants Fed A New Infant FormulaHealthyNCT01370967Société des Produits Nestlé (SPN)460
已完成
2 期
Effect of TU-100 in Patients With Functional ConstipationFunctional ConstipationNCT01348152Tsumura USA50
已完成
不适用
Breastfeeding StudyInfant Term BirthNCT03387124Société des Produits Nestlé (SPN)75
已完成
2 期
Effect of Chinese Herb on Chronic Constipation for Residents in Long-Term Care UnitsChronic ConstipationNCT00354575National Taiwan University Hospital168